Is the 21-Gene Recurrence Score on Core Needle Biopsy Equivalent to Surgical Specimen in Early-Stage Breast Cancer? A Comparison of Gene Expression Between Paired Core Needle Biopsy and Surgical Specimens

Background Molecular testing on surgical specimens predicts disease recurrence and benefit of adjuvant chemotherapy in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) early-stage breast cancer (EBC). Testing on core biopsies has become common practice despi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of surgical oncology 2021-10, Vol.28 (10), p.5588-5596
Hauptverfasser:	Orozco, Javier I. J., Chang, Shu-Ching, Matsuba, Chikako, Ensenyat-Mendez, Miquel, Grunkemeier, Gary L., Marzese, Diego M., Grumley, Janie G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biopsy Breast cancer Breast Oncology Chemotherapy DNA microarrays Epidermal growth factor ErbB-2 protein Gene expression Life Sciences & Biomedicine Medicine Medicine & Public Health Oncology Science & Technology Surgery Surgical Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!